Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Not stated	2026-06-23		NCT07663253

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Zhongshan Hospital	347

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Nantong University	Nantong	China	14
Fudan University Affiliated Zhongshan Hospital	Shanghai	China	2
Harbin Institute of Hematologic Oncology	Harbin	China	1
Henan Cancer Hospital	Zhengzhou	China	98
Jiangsu Provincial People's Hospital	Nanjing	China	21
Peking Union Medical College Hospital	Beijing	China	48
Shenzhen People's Hospital	Shenzhen	China	25
Sichuan Provincial People's Hospital	Chengdu	China	36
Sun Yat-Sen University Cancer Center	Guangzhou	China	113
The First Affiliated Hospital of Guangxi Medical University	Naning	China	1
The First Affiliated Hospital of Kunming Medical University	Kunming	China	17
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology.	Wuhan	China	2
Xijing Hospital, Air Force Medical University	Xi’an	China	2